Academic project funding

(awarded to CRG or to consortia participated by CRG)

ERC Proof of Concept grant 335010 “Mico pLung” (2014):  150,000€

ERC grant 670216 “MycoChassis” (2015):  2,454,522€

EU Horizon 2020 grant 634942 “MycoSynVac” (2015):  8,000,000€

EraSynBio “MiniCell” (2015):  200,000€

Miguel Servet ISCIII (2017):  121,500€

EU Horizon 2020 grant 820699 “BioRoboost” (2018):  1,998,787,50€

ERC Proof of Concept grant 825566 “MycoVAP” (2018):  150,000€

La Caixa Health “MycoVAP” (2019):   999,528€

 Pulmobiotics founding

Seed Investment by In Vivo Ventures (2020):  2,000,000 €

Two Torres Quevedo contracts (2021):  232.000 €

 Pulmobiotics

 A novel live biotherapeutic platform

for treating human lung diseases.